Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001567619-20-018747

Former 10% Owner acquired 6,411,355 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cormorant Asset Management, LP Former 10% Owner 2020-11-03 Conversion +6,411,355 6,411,355 I
Derivatives
Cormorant Asset Management, LP Former 10% Owner 2020-11-03 Conversion · Series A Convertible Preferred Stock −1,000,000 0 I
Cormorant Asset Management, LP Former 10% Owner 2020-11-03 Conversion · Series B Convertible Preferred Stock −1,650,165 0 I
Cormorant Asset Management, LP Former 10% Owner 2020-11-03 Conversion · Series C Convertible Preferred Stock −2,631,580 0 I
Cormorant Asset Management, LP Former 10% Owner 2020-11-03 Conversion · Series D Convertible Preferred Stock −712,250 0 I
Cormorant Asset Management, LP Former 10% Owner 2020-11-03 Conversion · Series D-1 Convertible Preferred Stock −417,360 0 I
Loading xslF345X03/doc1.xml…